Terms: = Breast cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Prognosis
73 results:
1. Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy.
Kim MW; Lee H; Lee S; Moon S; Kim Y; Kim JY; Kim SI; Kim JY
BMC Cancer; 2024 Feb; 24(1):185. PubMed ID: 38326737
[TBL] [Abstract] [Full Text] [Related]
2. Systematic screening identifies abcg2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors.
van der Noord VE; van der Stel W; Louwerens G; Verhoeven D; Kuiken HJ; Lieftink C; Grandits M; Ecker GF; Beijersbergen RL; Bouwman P; Le Dévédec SE; van de Water B
Breast Cancer Res; 2023 May; 25(1):51. PubMed ID: 37147730
[TBL] [Abstract] [Full Text] [Related]
3. New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells.
Buľková V; Vargová J; Babinčák M; Jendželovský R; Zdráhal Z; Roudnický P; Košuth J; Fedoročko P
Biomed Pharmacother; 2023 Jul; 163():114829. PubMed ID: 37146419
[TBL] [Abstract] [Full Text] [Related]
4. Thiosemicarbazide Derivatives Targeting Human TopoIIα and IDO-1 as Small-Molecule Drug Candidates for breast cancer Treatment.
Kaproń B; Czarnomysy R; Radomska D; Bielawski K; Plech T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982886
[TBL] [Abstract] [Full Text] [Related]
5. [Correlation between the mRNA levels of bcrp and LUNX genes and pathological types and stages of patients with non-small cell lung cancer].
Chen D; Han W; Wang P; Ma H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):202-207. PubMed ID: 36709941
[TBL] [Abstract] [Full Text] [Related]
6. ABC transporters in breast cancer: their roles in multidrug resistance and beyond.
Modi A; Roy D; Sharma S; Vishnoi JR; Pareek P; Elhence P; Sharma P; Purohit P
J Drug Target; 2022 Nov; 30(9):927-947. PubMed ID: 35758271
[TBL] [Abstract] [Full Text] [Related]
7. Germline and somatic genetic variability of oxysterol-related genes in breast cancer patients with early disease of the luminal subtype.
Holý P; Hlaváč V; Ostašov P; Brynychová V; Koževnikovová R; Trnková M; Kopečková K; Měšťáková S; Mrhalová M; Souček P
Biochimie; 2022 Aug; 199():158-169. PubMed ID: 35525372
[TBL] [Abstract] [Full Text] [Related]
8. Ko143 Reverses MDR in Glioblastoma
Lustig SD; Kodali SK; Longo SL; Kundu S; Viapiano MS
Anticancer Res; 2022 Feb; 42(2):723-730. PubMed ID: 35093870
[TBL] [Abstract] [Full Text] [Related]
9. Drug Resistance in Metastatic breast cancer: Tumor Targeted Nanomedicine to the Rescue.
Gote V; Nookala AR; Bolla PK; Pal D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemical Analysis of DNA Repair- and Drug-Efflux-Associated Molecules in Tumor and Peritumor Areas of Glioblastoma.
Angelucci C; D'Alessio A; Sorrentino S; Biamonte F; Moscato U; Mangiola A; Sica G; Iacopino F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562724
[TBL] [Abstract] [Full Text] [Related]
11.
Bhattacharya A; Mukherjee S; Khan P; Banerjee S; Dutta A; Banerjee N; Sengupta D; Basak U; Chakraborty S; Dutta A; Chattopadhyay S; Jana K; Sarkar DK; Chatterjee S; Das T
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082288
[TBL] [Abstract] [Full Text] [Related]
12. Effect of ABC transporter expression and mutational status on survival rates of cancer patients.
Kadioglu O; Saeed MEM; Munder M; Spuller A; Greten HJ; Efferth T
Biomed Pharmacother; 2020 Nov; 131():110718. PubMed ID: 32932043
[TBL] [Abstract] [Full Text] [Related]
13. Vielanin K enhances doxorubicin-induced apoptosis via activation of IRE1α- TRAF2 - JNK pathway and increases mitochondrial Ca
Zhang LN; Xia YZ; Zhang C; Zhang H; Luo JG; Yang L; Kong LY
Phytomedicine; 2020 Nov; 78():153329. PubMed ID: 32896708
[TBL] [Abstract] [Full Text] [Related]
14. ACLY: A biomarker of recurrence in breast cancer.
Chen Y; Li K; Gong D; Zhang J; Li Q; Zhao G; Lin P
Pathol Res Pract; 2020 Sep; 216(9):153076. PubMed ID: 32825949
[TBL] [Abstract] [Full Text] [Related]
15. Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling.
Yang H; Geng YH; Wang P; Yang H; Zhou YT; Zhang HQ; He HY; Fang WG; Tian XX
Oncogene; 2020 Aug; 39(35):5795-5810. PubMed ID: 32724162
[TBL] [Abstract] [Full Text] [Related]
16. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract] [Full Text] [Related]
17. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
[TBL] [Abstract] [Full Text] [Related]
18. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
Hu X; Chen F
Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
[No Abstract] [Full Text] [Related]
19. Downregulation of cytokeratin 18 enhances bcrp-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
[TBL] [Abstract] [Full Text] [Related]
20. Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human breast cancer Cells through Up-Regulation of IFIT2.
Koh SY; Moon JY; Unno T; Cho SK
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875792
[TBL] [Abstract] [Full Text] [Related]
[Next]
